Overview
The purpose of this study is to evaluate the soft tissue clinical results in patients that received, or not, a soft tissue augmentation around dental implant inserted immediately after the extraction.
Description
After being informed about the study and potential risks, all patients giving written informed consent will undergo a screening period to determinate eligibility for study entry. Patients who meet eligibility requirements will be randomized in this single blinded(investigator) study.
Group (Test) will receive immediate implant after extraction and a soft tissue augmentation with a collagen matrix.
Group (Control) will receive only immediate implant after extraction without soft tissue augmentation.
Eligibility
Inclusion Criteria:
- Presence of a single failing tooth in the esthetic region (second premolar to contralateral second premolar), the adjacent teeth should be present and without any dental pathologies.
Exclusion Criteria:
- Patients who are heavy smokers (more than 10 cigarettes/day);
- Patients who suffer from any systemic diseases that could negatively influence wound healing;
- Patients who received head and neck radiation treatment;
- Patients who have a full contraindication to implant surgery;
- Patients who have uncontrolled periodontal disease;
- Patients who show a full mouth plaque and bleeding score higher than 25%;
- Patients who have deficient extraction sockets according to the classification of Juodzbalys et al. 2008.
- Patients with known allergy, sensitivity or intolerance to collagen
- Patients who are pregnant or who are breastfeeding